FI951130A - PNa-syntes under användning av gentemot savaga syror labila aminoskyddsgrupper - Google Patents
PNa-syntes under användning av gentemot savaga syror labila aminoskyddsgrupper Download PDFInfo
- Publication number
- FI951130A FI951130A FI951130A FI951130A FI951130A FI 951130 A FI951130 A FI 951130A FI 951130 A FI951130 A FI 951130A FI 951130 A FI951130 A FI 951130A FI 951130 A FI951130 A FI 951130A
- Authority
- FI
- Finland
- Prior art keywords
- opt
- polymer
- formula
- protecting
- sic
- Prior art date
Links
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 125000006239 protecting group Chemical group 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 229920000642 polymer Polymers 0.000 abstract 5
- 108091093037 Peptide nucleic acid Proteins 0.000 abstract 3
- 230000008878 coupling Effects 0.000 abstract 3
- 238000010168 coupling process Methods 0.000 abstract 3
- 238000005859 coupling reaction Methods 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000010532 solid phase synthesis reaction Methods 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 125000004103 aminoalkyl group Chemical group 0.000 abstract 1
- 125000003435 aroyl group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 238000009396 hybridization Methods 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- C07K14/003—Peptide-nucleic acids (PNAs)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
- C08G69/10—Alpha-amino-carboxylic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4408531A DE4408531A1 (de) | 1994-03-14 | 1994-03-14 | PNA-Synthese unter Verwendung einer gegen schwache Säuren labilen Amino-Schutzgruppe |
| DE4408531 | 1994-03-14 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI951130A0 FI951130A0 (sv) | 1995-03-10 |
| FI951130A true FI951130A (sv) | 1995-09-15 |
| FI120261B FI120261B (sv) | 2009-08-31 |
Family
ID=6512696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI951130A FI120261B (sv) | 1994-03-14 | 1995-03-10 | PNA-syntes under användning av gentemot svaga syror labila aminoskyddsgrupper |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6046306A (sv) |
| EP (1) | EP0672700B1 (sv) |
| JP (1) | JP4098837B2 (sv) |
| AT (1) | ATE180805T1 (sv) |
| AU (1) | AU695931B2 (sv) |
| CA (1) | CA2144477C (sv) |
| DE (2) | DE4408531A1 (sv) |
| DK (1) | DK0672700T3 (sv) |
| ES (1) | ES2132450T3 (sv) |
| FI (1) | FI120261B (sv) |
| GR (1) | GR3030883T3 (sv) |
| NO (1) | NO321034B1 (sv) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7825215B1 (en) * | 1993-04-26 | 2010-11-02 | Peter E. Nielsen | Substituted nucleic acid mimics |
| US6133444A (en) * | 1993-12-22 | 2000-10-17 | Perseptive Biosystems, Inc. | Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions |
| US6150510A (en) | 1995-11-06 | 2000-11-21 | Aventis Pharma Deutschland Gmbh | Modified oligonucleotides, their preparation and their use |
| DE4438918A1 (de) * | 1994-11-04 | 1996-05-09 | Hoechst Ag | Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung |
| JP2001518054A (ja) * | 1995-06-07 | 2001-10-09 | パーセプティブ バイオシステムズ，インコーポレーテッド | Ｐｎａ−ｄｎａキメラと、このキメラ合成用のｐｎａシントン |
| US20050042647A1 (en) * | 1996-06-06 | 2005-02-24 | Baker Brenda F. | Phosphorous-linked oligomeric compounds and their use in gene modulation |
| US20050032068A1 (en) * | 2002-11-05 | 2005-02-10 | Prakash Thazha P. | Sugar and backbone-surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| US7812149B2 (en) | 1996-06-06 | 2010-10-12 | Isis Pharmaceuticals, Inc. | 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations |
| US9096636B2 (en) * | 1996-06-06 | 2015-08-04 | Isis Pharmaceuticals, Inc. | Chimeric oligomeric compounds and their use in gene modulation |
| US20040171030A1 (en) * | 1996-06-06 | 2004-09-02 | Baker Brenda F. | Oligomeric compounds having modified bases for binding to cytosine and uracil or thymine and their use in gene modulation |
| US5898031A (en) | 1996-06-06 | 1999-04-27 | Isis Pharmaceuticals, Inc. | Oligoribonucleotides for cleaving RNA |
| US20050118605A9 (en) * | 1996-06-06 | 2005-06-02 | Baker Brenda F. | Oligomeric compounds having modified bases for binding to adenine and guanine and their use in gene modulation |
| US20040266706A1 (en) * | 2002-11-05 | 2004-12-30 | Muthiah Manoharan | Cross-linked oligomeric compounds and their use in gene modulation |
| US6331618B1 (en) * | 1999-05-13 | 2001-12-18 | Pe Corporation (Ny) | Compositions of solvents and high concentrations of nucleic acid analogs |
| DE10019136A1 (de) * | 2000-04-18 | 2001-10-31 | Aventis Pharma Gmbh | Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung |
| DE10019135A1 (de) * | 2000-04-18 | 2001-10-31 | Aventis Pharma Gmbh | Polyamidnukleinsäure-Derivate, Mittel und Verfahren zu ihrer Herstellung |
| US9150606B2 (en) * | 2002-11-05 | 2015-10-06 | Isis Pharmaceuticals, Inc. | Compositions comprising alternating 2'-modified nucleosides for use in gene modulation |
| US9150605B2 (en) * | 2002-11-05 | 2015-10-06 | Isis Pharmaceuticals, Inc. | Compositions comprising alternating 2′-modified nucleosides for use in gene modulation |
| WO2004044132A2 (en) * | 2002-11-05 | 2004-05-27 | Isis Pharmaceuticals, Inc. | Modified oligonucleotides for use in rna interference |
| CA2504694C (en) * | 2002-11-05 | 2013-10-01 | Isis Pharmaceuticals, Inc. | Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| US8569474B2 (en) | 2004-03-09 | 2013-10-29 | Isis Pharmaceuticals, Inc. | Double stranded constructs comprising one or more short strands hybridized to a longer strand |
| US8394947B2 (en) | 2004-06-03 | 2013-03-12 | Isis Pharmaceuticals, Inc. | Positionally modified siRNA constructs |
| JP2008501693A (ja) * | 2004-06-03 | 2008-01-24 | アイシス ファーマシューティカルズ、インク． | 遺伝子調節で使用するための個別に調節された鎖を有する二本鎖組成物 |
| US7884086B2 (en) | 2004-09-08 | 2011-02-08 | Isis Pharmaceuticals, Inc. | Conjugates for use in hepatocyte free uptake assays |
| PT1966130E (pt) | 2005-12-23 | 2014-01-30 | Zealand Pharma As | Compostos miméticos de lisina modificados |
| DK2468724T3 (en) | 2006-12-21 | 2016-02-22 | Zealand Pharma As | Synthesis of pyrrolidine compounds |
| DK3618847T3 (da) | 2017-05-05 | 2021-05-25 | Boston Medical Ct Corp | GAP-junction-modulatorer af intercellulær kommunikation og deres anvendelse til behandling af diabetisk øjensygdom |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5015733A (en) * | 1983-12-20 | 1991-05-14 | California Institute Of Technology | Nucleosides possessing blocked aliphatic amino groups |
| US5367066A (en) * | 1984-10-16 | 1994-11-22 | Chiron Corporation | Oligonucleotides with selectably cleavable and/or abasic sites |
| DE4016596A1 (de) * | 1990-05-23 | 1991-11-28 | Hoechst Ag | Ein neues kupplungsreagenz fuer die peptidsynthese |
| DK51092D0 (da) * | 1991-05-24 | 1992-04-15 | Ole Buchardt | Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf |
| MX9207334A (es) * | 1991-12-18 | 1993-08-01 | Glaxo Inc | Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene |
-
1994
- 1994-03-14 DE DE4408531A patent/DE4408531A1/de not_active Withdrawn
-
1995
- 1995-03-08 AT AT95103318T patent/ATE180805T1/de active
- 1995-03-08 ES ES95103318T patent/ES2132450T3/es not_active Expired - Lifetime
- 1995-03-08 DE DE59506063T patent/DE59506063D1/de not_active Expired - Lifetime
- 1995-03-08 DK DK95103318T patent/DK0672700T3/da active
- 1995-03-08 EP EP95103318A patent/EP0672700B1/de not_active Expired - Lifetime
- 1995-03-10 FI FI951130A patent/FI120261B/sv not_active IP Right Cessation
- 1995-03-10 AU AU14801/95A patent/AU695931B2/en not_active Ceased
- 1995-03-13 NO NO19950957A patent/NO321034B1/no not_active IP Right Cessation
- 1995-03-13 CA CA002144477A patent/CA2144477C/en not_active Expired - Fee Related
- 1995-03-14 JP JP05464295A patent/JP4098837B2/ja not_active Expired - Fee Related
-
1997
- 1997-09-11 US US08/927,178 patent/US6046306A/en not_active Expired - Lifetime
-
1999
- 1999-07-30 GR GR990401964T patent/GR3030883T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0672700B1 (de) | 1999-06-02 |
| AU1480195A (en) | 1995-09-21 |
| NO950957L (no) | 1995-09-15 |
| NO950957D0 (no) | 1995-03-13 |
| JP4098837B2 (ja) | 2008-06-11 |
| US6046306A (en) | 2000-04-04 |
| DE4408531A1 (de) | 1995-09-28 |
| DK0672700T3 (da) | 1999-11-29 |
| AU695931B2 (en) | 1998-08-27 |
| ATE180805T1 (de) | 1999-06-15 |
| JPH07285989A (ja) | 1995-10-31 |
| EP0672700A1 (de) | 1995-09-20 |
| GR3030883T3 (en) | 1999-11-30 |
| FI120261B (sv) | 2009-08-31 |
| FI951130A0 (sv) | 1995-03-10 |
| NO321034B1 (no) | 2006-03-06 |
| ES2132450T3 (es) | 1999-08-16 |
| CA2144477C (en) | 2007-09-18 |
| CA2144477A1 (en) | 1995-09-15 |
| DE59506063D1 (de) | 1999-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI951130A0 (sv) | PNa-syntes under användning av gentemot savaga syror labila aminoskyddsgrupper | |
| Geckeler | Soluble polymer supports for liquid-phase synthesis | |
| DK0552766T3 (da) | Oligonukleotidanaloger, deres fremstilling og anvendelse | |
| Hernández et al. | Synthesis and ring‐opening (co) polymerization of L‐lysine N‐carboxyanhydrides containing labile side‐chain protective groups | |
| HUP0102900A2 (hu) | Javított szilárd fázisú peptidszintézis és a szintézisben alkalmazható anyagok | |
| WO2005108411A2 (en) | Substituted pixyl protecting groups for oligonucleotide synthesis | |
| CY1110982T1 (el) | Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων | |
| WO2007069092B1 (en) | Cationic oligonucleotides, automated methods for preparing same and their uses | |
| DK1442198T3 (da) | Fremgangsmåde til opbrydning af en underjordisk formation ved brug af gelerende syrer | |
| NO996097L (no) | Lag-3 spleis varianter | |
| DK0672701T3 (da) | PNA-syntese under anvendelse af en baselabil aminobeskyttelsesgruppe | |
| EP0906917A3 (en) | Method for chemical synthesis of oligonucleotides | |
| DK0818460T3 (da) | Fastfasesyntese af oligonucleotider | |
| CA2406169A1 (en) | Polyamide nucleic acid derivatives, and agents and processes for preparing them | |
| Wang et al. | Solid phase synthesis of neutral oligonucleotide analogues | |
| Seitz et al. | Convergent strategies for the attachment of fluorescing reporter groups to peptide nucleic acids in solution and on solid phase | |
| Slaitas et al. | A Novel N‐(Pyrrolidinyl‐2‐methyl) glycine‐Based PNA with a Strong Preference for RNA over DNA | |
| US7892737B2 (en) | Compositions, kits and methods pertaining to stability modulation of PNA oligomer/nucleic acid complexes | |
| Uhlmann et al. | Synthesis of polyamide nucleic acids (PNAs), PNA/DNA-chimeras and phosphonic ester nucleic acids (PHONAs) | |
| KR20060015512A (ko) | 신규 기능성 펩티드 핵산 및 그 제법 | |
| Diss et al. | Facile production of mono‐substituted urea side chains in solid phase peptide synthesis | |
| Slaitas | Development of a new PNA analogue as a potential antisense drug and tool for life-science studies | |
| Scheibe et al. | Identification of neighbouring proteins by cross-linking of intact 70 S ribosomes from Escherichia coli | |
| Mei et al. | Figure 14 E xamples of multiple-component reactions for both solid-phase and solution-phase synthesis of heterocycles. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 120261 Country of ref document: FI |
|
| MM | Patent lapsed |